PRTA

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Prothena Corporation plc

NASDAQ | PRTA

10.75

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$561.45M

Market Cap

-

P/E Ratio

-5.2

EPS

$17.66

52 Week High

$4.32

52 Week Low

HEALTHCARE

Sector

PRTA Chart

Recent Chart
Price Action

PRTA Technicals

Tags:

PRTA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $135M
Total Revenue $135M
Cost Of Revenue $3.6M
Costof Goods And Services Sold $3.6M
Operating Income -$155M
Selling General And Administrative $67M
Research And Development $223M
Operating Expenses $290M
Investment Income Net -
Net Interest Income $26M
Interest Income $26M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $893K
Income Before Tax -$129M
Income Tax Expense -$6.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$122M
Comprehensive Income Net Of Tax -
Ebit -$155M
Ebitda -$154M
Net Income -$122M

Revenue & Profitability

Earnings Performance

PRTA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $547M
Total Current Assets $485M
Cash And Cash Equivalents At Carrying Value $471M
Cash And Short Term Investments $471M
Inventory -
Current Net Receivables $0
Total Non Current Assets $62M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $14M
Other Non Current Assets -
Total Liabilities $60M
Total Current Liabilities $49M
Current Accounts Payable $7.8M
Deferred Revenue -
Current Debt -
Short Term Debt $2.6M
Total Non Current Liabilities $12M
Capital Lease Obligations $11M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $11M
Other Current Liabilities $29M
Other Non Current Liabilities -
Total Shareholder Equity $487M
Treasury Stock -
Retained Earnings -$1.1B
Common Stock $538K
Common Stock Shares Outstanding $54M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$150M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $893K
Capital Expenditures $298K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$298K
Cashflow From Financing $1.6M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$353K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$122M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $135M
Total Revenue $135M
Cost Of Revenue $3.6M
Costof Goods And Services Sold $3.6M
Operating Income -$155M
Selling General And Administrative $67M
Research And Development $223M
Operating Expenses $290M
Investment Income Net -
Net Interest Income $26M
Interest Income $26M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $893K
Income Before Tax -$129M
Income Tax Expense -$6.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$122M
Comprehensive Income Net Of Tax -
Ebit -$155M
Ebitda -$154M
Net Income -$122M

PRTA News

PRTA Profile

Prothena Corporation plc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Prothena Corporation plc is a clinical-stage biotechnology company headquartered in Dublin, Ireland, specializing in the discovery and development of novel therapeutics for severe, life-threatening diseases. The company boasts a promising pipeline targeting neurodegenerative disorders linked to protein misfolding, including Alzheimer's disease, thereby addressing significant unmet medical needs. By leveraging cutting-edge scientific research and a robust intellectual property portfolio, Prothena is well-positioned to become a leader in the biopharmaceutical sector, with the potential to deliver transformative treatments that enhance patient outcomes globally.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
ONDS
-2.36%
$8.24
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.53%
$33.18
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
INHD
-0.97%
$0.22
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
CHR
-3.48%
$0.04
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
F
+0.45%
$13.25
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
MTSR
-0.35%
$70.50
IREN
+2.06%
$48.45
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.40%
$7.82
AFMD
-34.94%
$0.18
PFE
0.00%
$25.71
SMX
+250.80%
$61.04
CRCL
+10.02%
$79.92
KWM
+13.63%
$0.75
DNN
-0.19%
$2.55
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
VEEE
+45.50%
$2.59
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
CAN
+9.78%
$1.01
WBD
+0.50%
$24.00
AIIO
-9.09%
$0.70
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
GOOG
-0.05%
$320.12
NGD
+6.76%
$8.37
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
KSS
+7.49%
$24.10
BTE
-0.31%
$3.16
RR
-3.35%
$3.46
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
KDLY
+7.20%
$0.49
T
+0.69%
$26.00
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
MSFT
+1.34%
$492.01
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
ONDS
-2.36%
$8.24
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.53%
$33.18
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
INHD
-0.97%
$0.22
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
CHR
-3.48%
$0.04
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
F
+0.45%
$13.25
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
MTSR
-0.35%
$70.50
IREN
+2.06%
$48.45
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.40%
$7.82
AFMD
-34.94%
$0.18
PFE
0.00%
$25.71
SMX
+250.80%
$61.04
CRCL
+10.02%
$79.92
KWM
+13.63%
$0.75
DNN
-0.19%
$2.55
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
VEEE
+45.50%
$2.59
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
CAN
+9.78%
$1.01
WBD
+0.50%
$24.00
AIIO
-9.09%
$0.70
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
GOOG
-0.05%
$320.12
NGD
+6.76%
$8.37
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
KSS
+7.49%
$24.10
BTE
-0.31%
$3.16
RR
-3.35%
$3.46
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
KDLY
+7.20%
$0.49
T
+0.69%
$26.00
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
MSFT
+1.34%
$492.01
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.